Patient Characteristics
We accrued 18 patients between March 2017 through December 2019. The timing of the dose expansion coincided with the COVID-19 pandemic, limiting accrual and, as a result, only 2 of the 10 planned patients for expansion were accrued. The demographics of these 18 patients are shown in Patient demographics
